Interestingly, the BRCA1/2‐positive rate was similar among different age groups in the OV cohort, which was different from the BROV cohort, as well as the BRCA‐positive breast cancer patients in our previous study (Kwong et al., 2009). This evidence concerns the gene BRCA1 and breast cancer.